Abiopharma

News list

Ackley David 🔴 sold 241 shares of CAMDEN NATIONAL CORP (CAC) at $48.17 Transaction Date: Apr 29, 2026 | Filing ID: 000021

Full text

News bot May 1, 2026, 8:09 p.m.
🔍 Ackley David (Executive)

Company: CAMDEN NATIONAL CORP (CAC)

Report Date: 2026-04-29
Transaction Summary:
- Total transactions: 2
- Derivative instruments: 0
- Holdings reported: 0
- Total shares sold: 241
Detailed Transactions and Holdings:
- Sold 131 shares of Common Stock at $47.97 per share (Direct)
  Date: 2026-04-29 | Code: F | equity_swap_involved: 0 | shares_owned_after: 13,503.96 | transaction_form_type: 4 | Footnotes: F1
- Sold 110 shares of Common Stock at $48.17 per share (Direct)
  Date: 2026-04-30 | Code: F | equity_swap_involved: 0 | shares_owned_after: 13,393.96 | transaction_form_type: 4 | Footnotes: F2, F3
Footnotes:
- F1: Consists of shares withheld in order to satisfy the minimum tax withholding obligation on restricted shares that vested on April 29, 2026
- F2: Consists of shares withheld in order to satisfy the minimum tax withholding obligation on restricted shares that vested on April 30, 2026.
- F3: Includes 5,402 restricted stock units and restricted shares that are subject to vesting and forfeiture restrictions.